Kisqali (Ribociclib) on The 11th Hour with Stephanie Ruhle

I'm Lindsay, and even before my diagnosis, my hands were full as a mom and an investigator. After treating my HR-positive, HER2-negative early breast cancer, I wanted to do everything I could to try to keep it from coming back. So I talked to my doctor about a treatment plan that included Cascali. Kiskali Ribocyclibs 200-milligram tablets with an aromatase inhibitor is for adults with HR-positive, HER2-negative, stage 2 or 3 early breast cancer with a high risk of coming back. Kiskali may cause serious skin reactions, liver problems, and low white blood cell counts that may result in serious infections. Life-threatening lung problems and abnormal heartbeats can occur. Your doctor should test your heart and blood before and during treatment. Tell your doctor if you have new or worsening cough, chest pain, or dizziness. Before taking Kiskali, tell your doctor all your medical conditions, medicines you take, and if you're breastfeeding, pregnant, or planning to be, as it can harm an unborn baby. Common side effects include nausea, headache, and tiredness. Lindsay is a real patient, compensated for her time. Learn more at cascali.com.